genome2life

Newton, Massachusetts, United States

Genome2Life is transforming precision medicine by addressing long-standing gaps in women’s health, cancer, and autoimmune care. Through our proprietary platform integrating genomics, immune profiling, and cell differentiation, we enable early detection, real-time monitoring, and personalized therapeutics for conditions that disproportionately affect women. Historically, women have been underrepresented in clinical research, leading to delayed diagnoses and ineffective treatments—particularly in autoimmune disorders, fertility, and cancers such as breast and ovarian. Genome2Life is closing this data gap with scalable, evidence-based solutions designed to modernize diagnostics and deliver more equitable, targeted care across both human and animal health.